Stratagene Hopes Instrument Launches, Patent Reinstatement Will Aid Revenue Growth in 2007 | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Stratagene expects its partnerships for molecular diagnostics and pharmacogenomics will result in new instrument launches in 2007 and 2008, and hopes that the reinstatement of a key patent will provide it with leverage in negotiations with rivals.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.